SUN PHARMACEUTICAL INDUSTRIES
Back to All Ratios
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 19.89 | 17.60 | 17.24 | 9.28 | 5.66 |
What is the latest Return on Capital Employed (ROCE) ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 19.89 |
| Mar2024 | 17.60 |
| Mar2023 | 17.24 |
| Mar2022 | 9.28 |
| Mar2021 | 5.66 |
How is Return on Capital Employed (ROCE) of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 19.89 | 13.01 | |
| Mar2024 | 17.6 | 2.09 | |
| Mar2023 | 17.24 | 85.78 | |
| Mar2022 | 9.28 | 63.96 | |
| Mar2021 | 5.66 | - | |
Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,188.5 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,961.6 Cr | 5.8% | 1.9% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 3% |
9.5% |
3.1% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses